Text Size
472 studies found for:    Thrombocytopenia: Clinical Trials

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Active, not recruiting WEUSKOP5410: Observational Study in ENABLE Clinical Trials
Conditions: Phlebitis;   Hepatitis C;   Unstable Angina;   Deep Vein Thrombosis;   Ischemic Stroke;   Pulmonary Embolism;   Ischaemic Attack, Transient;   Thrombocytopenia;   Thrombophlebitis;   Myocardial Infarction;   Portal Vein Thrombosis
Intervention: Drug: eltrombopag
2 Recruiting A Pilot Study of a Thrombopoietin-Receptor Agonist (TPO-R Agonist), Eltrombopag, in Aplastic Anemia Patients With Immunosuppressive-Therapy Refractory Thrombocytopenia
Conditions: Anemia, Aplastic;   Anemia, Hypoplastic;   Thrombocytopenia
Interventions: Drug: Eltrombopag (Promacta);   Drug: Eltrombopag
3 Not yet recruiting A Study to Investigate Belimumab for the Treatment of Chronic Immune Thrombocytopenia.
Condition: Purpura, Thrombocytopaenic, Idiopathic
Interventions: Drug: Belimumab;   Drug: Normal saline placebo
4 Active, not recruiting Study of a New Medication for Childhood Chronic Immune Thrombocytopenia (ITP), a Blood Disorder of Low Platelet Counts That Can Lead to Bruising Easily, Bleeding Gums, and/or Bleeding Inside the Body.
Condition: Oedema
Interventions: Drug: Eltrombopag;   Drug: Placebo
5 Completed Heparin-Induced Thrombocytopenia - Retrospective Analysis of Data on Incidence and Outcomes Study
Condition: Heparin Induced Thrombocytopenia
Intervention:
6 Active, not recruiting A Prospective, Study Evaluating Changes in Bone Marrow Morphology in Adult Subjects Receiving Romiplostim for the Treatment of Thrombocytopenia Associated With Immune (Idiopathic) Thrombocytopenia Purpura (ITP)
Conditions: Thrombocytopenia;   Idiopathic Thrombocytopenic Purpura
Intervention: Biological: romiplostim
7 Unknown † A Study on the Prevalence of Heparin-Induced Thrombocytopenia in Cardiovascular Patients
Condition: Heparin-Induced Thrombocytopenia
Intervention:
8 Recruiting A Three-part Study of Eltrombopag in Thrombocytopenic Subjects With Myelodysplastic Syndromes or Acute Myeloid Leukemia
Condition: Thrombocytopaenia
Interventions: Drug: eltrombopag;   Drug: placebo
9 Unknown † The HIT-TRAP Trial
Condition: Heparin-Induced Thrombocytopenia
Intervention: Drug: Standard heparin (UFH) versus certoparin (LMWH)
10 Completed Efficacy and Safety Study of Argatroban to Treat Heparin-Induced Thrombocytopenia
Condition: Heparin-Induced Thrombocytopenia
Intervention: Drug: argatroban
11 Completed An Open-label Safety Study of S-888711
Condition: Immune Thrombocytopenia
Intervention: Drug: 0.5 mg of S-888711
12 Recruiting A Single Arm Pilot Study of Azacitidine in Myelodysplastic Syndromes (MDS) / Acute Myeloid Leukaemia (AML), With Eltrombopag Support for Thrombocytopenia
Conditions: Myelodysplastic Syndromes (MDS);   Acute Myeloid Leukaemia (AML)
Intervention: Drug: Azacitidine and eltrombopag
13 Completed Dose Finding Study Of Oral Eltrombopag In Patients With Sarcoma Receiving Adriamycin And Ifosfamide
Conditions: Sarcoma;   Thrombocytopenia;   Thrombocytopaenia;   Thrombopoiesis
Intervention: Drug: eltrombopag
14 Terminated A Study to Investigate the Efficacy and Safety of S-888711 Tablets Administered to Adult Subjects With Immune Thrombocytopenia (ITP)
Condition: Immune Thrombocytopenia (ITP)
Interventions: Drug: placebo to S-888711;   Drug: S-888711
15 Terminated Safety/Efficacy Study of a Drug to Reduce Thrombocytopenia in Patients Receiving Chemotherapy for Ovarian, Fallopian Tube or Peritoneal Cancer
Conditions: Thrombocytopenia;   Neutropenia;   Lymphopenia;   Anemia
Intervention: Drug: Angiotensin 1-7
16 Completed SB497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adults With Thrombocytopenia Due To Hepatitis C
Conditions: Hepatitis C, Chronic;   Hepatitis C;   Thrombocytopenia
Interventions: Drug: SB497115;   Other: Placebo
17 Recruiting Safety and Efficacy Study for Solid Tumor Patients Treated With Eltrombopag
Condition: Thrombocytopaenia
Interventions: Drug: Eltrombopag olamine;   Other: Placebo
18 Recruiting A Study of the Safety and Efficacy of ONO-7746 in Adult Cancer Patients With Chemotherapy Induced Thrombocytopenia
Condition: Chemotherapy-Induced Thrombocytopenia
Intervention: Drug: ONO-7746
19 Terminated
Has Results 		Evaluating the Presence of Blood Clots in People With Heparin-Induced Thrombocytopenia (HIT) (The HOT Study)
Condition: Thrombocytopenia
Intervention:
20 Recruiting Rivaroxaban for Treatment of Patients With Suspected or Confirmed Heparin-Induced Thrombocytopenia
Condition: Heparin-induced Thrombocytopenia
Intervention: Drug: Rivaroxaban
To Top

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
† Indicates status has not been verified in more than two years